Abemaciclib Package Insert

KISQALI® (ribociclib) Oral Tablet KISQALI® FEMARA® CO-PACK ...
Fax completed prior authorization request form to 602-864-3126 or email to pharmacyprecert@azblue.com. Call 866-325-1794 to check the status of a request. All requested data must be provided. ... Access Doc

University Health Network - Formularyacademy.com
Package insert. Other frequent adverse events included leukopenia, anemia and GI events. No safety information is provided for use in pregnancy; therefore, contraception should be used during and after treatment. Additional clinical trials are on-going for ribociclib for its use in metastatic or recurring breast cancer, as well as other cancer ... Document Viewer

PowerPoint Presentation
Abemaciclib versus docetaxel is being investigated in a randomized Phase II trial as second-line therapy in patients with stage IV squamous NSCLC—estimated primary completion date is January 20175 Abemaciclib plus pembrolizumab is being investigated in a Phase II trial as second-line or beyond therapy in patients with stage IV NSCLC or breast ... Fetch Full Source

Evolution Of Endocrine Therapy In Breast Cancer
Evolution of Endocrine Therapy in Breast Cancer Sara A. Hurvitz, MD, FACP [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2011. 4 Abemaciclib: Phase I (MBC Data) MTD single agent, continuous dosing 200 mg q12 hours ... Document Viewer

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
2 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. ... Get Doc

Grapefruit - Wikipedia
One whole grapefruit, or a glass of 200 mL (6.8 US fl oz) of grapefruit juice may cause drug overdose toxicity. Typically, drugs that are incompatible with grapefruit are so labeled on the container or package insert. People taking drugs should ask their health care provider or pharmacist questions about grapefruit and drug interactions. ... Read Article

CY2018 Genesis-Orion Prior Authorization Protocols
ABEMACICLIB Products Affected / Producto Afectado VERZENIO PA Criteria Criteria Details Covered Uses All FDA approved indications not otherwise excluded from Part D Other Criteria (a) Follow Package insert instructions for dose administration. ... Access Document

Michigan.fhsc.com
5/3/2010. 7/25/2009. 3/1/2014. 6/1/2012. 7/1/2013. 3/1/2014. 12/1/2016. 11/21/2009. 5/3/2010. 11/21/2009. 4/1/2017. 11/21/2009. 4/1/2017. 9/1/2018. 12/1/2012. 11/1 ... Return Document

Last Review Status/Date - Media.fepblue.org
Verzenio(abemaciclib) Background . Verzenio is a prescription medication that is a kinase inhibitor that works by blocking certain molecules (known as cyclin-dependent kinases 4 and 6), involved in promoting the growth of cancer cells. Verzenio provides a new targeted treatment option for certain patients with breast ... Retrieve Document

NEW DRUG UPDATE 2018 - Tshp.org
1. Discuss the basic pharmacology of the new drugs presented and how the pharmacologic actions relate to both therapeutic and adverse effects. ... Read Content

Abemaciclib (Verzenio ), De Lilly, Recibe Una Aprobación ...
Abemaciclib (Verzenio®), de 3 Verzenio [package insert]. Indianapolis, IN: Eli Lilly and Company; 2018. 4 Data on file. Lilly USA, LLC. ONC20180122a. - 3 - “Esta información nos ayudará como base para la toma de decisiones para cada paciente, que ... Fetch Full Source

Collaborative Management Of Patients With Advanced Estrogen ...
Financial Disclosure • Dr. Schwartzberg has served on the speakers bureau for Novartis and acted as a consultant for Pfizer. • Ms. Greene has served on the speakers bureau for Pfizer. ... Read Here

CY2018 Apollo-Olympus Prior Authorization Protocols
ABEMACICLIB Products Affected / Producto Afectado VERZENIO PA Criteria Criteria Details Covered Uses All FDA approved indications not otherwise excluded from Part D Other Criteria (a) Follow Package insert instructions for dose administration. ... View Doc

HIGHLIGHTS OF PRESCRIBING INFORMATION ...
2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Ovarian Cancer GEMZAR®in combination with carboplatin is indicated for the treatment of patients with advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy. ... Fetch Full Source

References I-123 - Secure.highmark.com
10. Faslodex® (Fulvestrant) for injection [package insert]. Wilmington, DE, AstraZeneca Pharmaceuticals LP. Revised 11/2017. 11. Sledge GW, Toi M, Neven P, Sohn J, Inoue K, Pivot X, et al. MONARCH 2: abemaciclib in combination with fulvestrant in women with HR+/HER2- advanced breast cancer who had progressed while receiving endocrine therapy. ... Return Document

Faslodex® (fulvestrant) - Modahealth.com
1. Faslodex [package insert]. Wilmington, DE; AstraZeneca Pharmaceuticals LP; November 2017. Accessed January 2018. 2. Referenced with permission from the NCCN Drugs & Biologics Compendium (NCCN Compendium®) for fulvestrant. National Comprehensive Cancer Network, 2018. The NCCN Compendium® is a derivative work of the NCCN Guidelines®. NATIONAL ... Access Doc

Faslodex® (fulvestrant) - Magellan Provider
1. Faslodex [package insert]. Wilmington, DE; AstraZeneca Pharmaceuticals LP; November 2017. Accessed March 2018. 2. Referenced with permission from the NCCN Drugs & Biologics Compendium (NCCN Compendium®) for fulvestrant. National Comprehensive Cancer Network, 2018. The NCCN Compendium® is a derivative work of the NCCN Guidelines®. NATIONAL ... Get Content Here

Enhancing Endocrine Therapy For Hormone Receptor Positive ...
Hormone Receptor Positive Advanced Breast Cancer Sung-BaeKim, MD, PhD Professor, Deptof Oncology, 5. Faslodex [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2011. SERMS4 •Tamoxifen Abemaciclib Palbociclib Ribociclib ... Fetch Here